Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Trillium Therapeutics Inc (TRIL.TO)

Trillium Therapeutics Inc (TRIL.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,325,642
  • Shares Outstanding, K 104,995
  • Annual Sales, $ 148 K
  • Annual Income, $ -59,346 K
  • 60-Month Beta 1.98
  • Price/Sales 41,211.28
  • Price/Cash Flow N/A
  • Price/Book 7.71
Trade TRIL.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.45
  • Most Recent Earnings -0.18 on 08/13/21
  • Next Earnings Date 11/15/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Options Overview Details

View History
  • Implied Volatility 18.53%
  • Historical Volatility 12.47%
  • IV Percentile 12%
  • IV Rank 10.72%
  • IV High 170.21% on 03/12/21
  • IV Low 0.31% on 09/14/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 8

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.23
  • Number of Estimates 2
  • High Estimate -0.21
  • Low Estimate -0.25
  • Prior Year -0.09
  • Growth Rate Est. (year over year) -155.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.59 +2.59%
on 10/18/21
22.79 -2.81%
on 09/29/21
-0.16 (-0.72%)
since 09/22/21
3-Month
7.48 +196.12%
on 08/20/21
22.79 -2.81%
on 09/29/21
+12.88 (+138.94%)
since 07/22/21
52-Week
7.48 +196.12%
on 08/20/21
27.12 -18.33%
on 11/30/20
+4.67 (+26.72%)
since 10/22/20

Most Recent Stories

More News
Two Trillion-Dollar Industries Being Transformed By Tech

Big money is pouring into two disruptive segments in two of the world’s biggest industries - ...

BEP : 37.91 (-0.03%)
PLUG : 32.70 (-2.88%)
TRUE.CN : 2.550 (+0.39%)
DXD : 8.56 (-0.58%)
TRIL.TO : 22.15 (+0.32%)
PBH.TO : 134.75 (+0.16%)
ONC.TO : 2.79 (-1.41%)
CRH.TO : 4.99 (+0.40%)
A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector

A massive disruption now appears imminent in one of the world’s largest – and most important ...

TRUE.CN : 2.550 (+0.39%)
TREIF : 2.0700 (-0.48%)
TRIL.TO : 22.15 (+0.32%)
ONC.TO : 2.79 (-1.41%)
HEXO.TO : 2.11 (-6.22%)
FTRP.CN : 5.550 (+1.46%)
Trillium, Analog Devices rise: General Motors, Lennar fall

Stocks that traded heavily or had substantial price changes Monday:

GM : 57.77 (-1.10%)
LEN : 100.50 (-0.91%)
OXY : 33.93 (+3.45%)
PFE : 43.16 (+0.70%)
ADI : 178.42 (-0.22%)
MSGE : 69.53 (-0.61%)
TRIL.TO : 22.15 (+0.32%)
Pfizer to pay $2.26B for cancer treatment developer Trillium

Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments.

PFE : 43.16 (+0.70%)
TRIL.TO : 22.15 (+0.32%)
This Could Massively Disrupt the $24.35 Billion NSAID Market

As the standard first-line treatment for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, ...

TRIL : 17.91 (+0.28%)
EDSA : 7.70 (-5.41%)
ACRS : 16.35 (+1.62%)
BMY : 57.60 (-0.36%)
ATBPF : 0.6916 (-2.47%)
TRIL.TO : 22.15 (+0.32%)
ATE.TO : 0.87 (-2.25%)
Psychedelic Stocks Might Take Off In 2021

The global market for psychedelic drug treatments and therapy is in the early stages of what looks ...

AGN : 193.02 (+0.02%)
MRK : 81.15 (-0.02%)
TRIL.TO : 22.15 (+0.32%)
ONC.TO : 2.79 (-1.41%)
OGI.TO : 2.87 (-4.65%)
FTRP.CN : 5.550 (+1.46%)
Stocks in play: Trillium Therapeutics Inc.

Has dosed the first multiple myeloma patient with TTI-622 (SIRPa-IgG4 Fc), an investigational checkpoint ...

TRIL.TO : 22.15 (+0.32%)
Ancient Aztec Medicine Could Be A Gamechanger For Mental Health

Thousands of years ago, ancient Aztecs may have held the key to the next biotech breakthrough. During ...

TRIL.TO : 22.15 (+0.32%)
ONC.TO : 2.79 (-1.41%)
FTRP.CN : 5.550 (+1.46%)
TSX Builds on Gains

Equities in Toronto moved progressively higher Thursday, hovering around nine-month highs as declines ...

TRIL.TO : 22.15 (+0.32%)
Stocks in play: Trillium Therapeutics Inc.

Announced the presentation of clinical data at the upcoming American Society of Hematology Annual Meeting, ...

TRIL.TO : 22.15 (+0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 22.35
2nd Resistance Point 22.25
1st Resistance Point 22.20
Last Price 22.15
1st Support Level 22.05
2nd Support Level 21.95
3rd Support Level 21.90

See More

52-Week High 27.12
Last Price 22.15
Fibonacci 61.8% 19.62
Fibonacci 50% 17.30
Fibonacci 38.2% 14.98
52-Week Low 7.48

See More

Business Summary

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar